Daniel Tan Shao Weng

36PUBLICATIONS

277CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (36)

Sort by Publication Date:

|Jul 10, 2026

Rethinking Molecular Profiling Post First-Line Osimertinib.

|May 13, 2026

Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial.

|Mar 26, 2026

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Jan 15, 2026

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Jun 14, 2025

Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects.

Timothy A Yap, David S P Tan, Anastasios Stathis

|Jun 01, 2025

Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab.

Zofia Piotrowska, Antonio Passaro, Danny Nguyen

Pageof 6

Frequent Collaborators

7 joint publications

Anders Jacobsen Skanderup

Benjamin J Solomon

Aaron C Tan

Vivek Subbiah

Alexander Drilon

Jianbin Chen

Marina-Chiara Garassino

3 joint publications

Wan-Teck Lim

3 joint publications

Gillianne G Y Lai

3 joint publications

Stephen V Liu

Frequent Collaborators

7 joint publications

Anders Jacobsen Skanderup

5 joint publications

Benjamin J Solomon

5 joint publications

Aaron C Tan

4 joint publications

Vivek Subbiah